Skip to the page

Data / Drug companies / Advanced Rx of Tennessee, LLC

Advanced Rx of Tennessee, LLC: 534 products in the FDA NDC directory, labeler code 80425

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Advanced Rx of Tennessee, LLC (labeler code 80425) lists 534 products in the FDA National Drug Code Directory, covering 169 finished drugs by generic name. By type: 509 prescription drugs, 19 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 11, 2026.

The request: Watch Advanced Rx of Tennessee, LLC (FDA labeler code 80425): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
80425
Products in commercial distribution
534
Packages
1,279
Finished drugs by generic name
169
Prescription products
509
Over the counter products
19
Controlled substance products
Schedule III 8, Schedule IV 49, Schedule V 25
Started marketing in the last 12 months
37
Products with a marketing end date set
3
Earliest marketing start
December 10, 1986
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)47188.2%
Other unapproved drugs254.7%
Authorized generics (NDA)163%
Over the counter monograph drugs152.8%
Bulk ingredients for compounding40.7%
Drugs for further processing20.4%
New drug applications (NDA)10.2%

Products by type

TypeProductsShare
Prescription drugs50995.3%
Over the counter drugs193.6%
Bulk ingredients40.7%
Drugs for further processing20.4%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Pregabalin2454
Diclofenac sodium19109
Gabapentin1991
Prednisone1449
Baclofen1365
Lidocaine12216
Meloxicam1254
Celecoxib1163
Ibuprofen11190
Venlafaxine hydrochloride1048
Zolpidem tartrate1038
Topiramate1056
Eszopiclone1029
Methocarbamol867
Naproxen758
Amitriptyline hydrochloride735
Cyclobenzaprine hcl63
Tramadol hcl62
Etodolac631
Ondansetron652
Tizanidine hcl61
Omeprazole6106
Pantoprazole sodium654
Alprazolam537
Cyclobenzaprine hydrochloride561
Metaxalone538
Clonazepam536
Trazodone hydrochloride539
Tramadol hydrochloride544
Tizanidine538
Esomeprazole magnesium577
Ketorolac tromethamine569
Duloxetine hcl41
Rabeprazole sodium420
Cephalexin436
Sucralfate439
Duloxetine436
Buspirone hydrochloride450
Diazepam451
Ibuprofen and famotidine414
Azithromycin dihydrate420
Sumatriptan428
Bupropion hydrochloride467
Chlorzoxazone421
Acetaminophen and codeine phosphate424
Hydroxyzine hydrochloride451
Ondansetron hcl31
Levofloxacin342
Doxycycline hyclate361
Ramelteon329
Lidocaine and menthol317
Allopurinol354
Nabumetone330
Methylprednisolone331
Naproxen sodium3100
Cefadroxil315
Propranolol hydrochloride351
Dexamethasone345
Quetiapine fumarate333
Sulfamethoxazole and trimethoprim348
Dexamethasone sodium phosphate225
Temazepam228
Butalbital, acetaminophen and caffeine223
Glipizide239
Citalopram231
Mupirocin229
Albuterol sulfate246
Desonide215
Moxifloxacin219
Sertraline hydrochloride255
Diclofenac potassium242
Methocarbamol tablets220
Famotidine2138
Imipramine hydrochloride214
Doxepin hydrochloride245
Clindamycin hcl21
Amoxicillin and clavulanate potassium235
Lidocaine hydrochloride2134
Tizanidine hydrochloride225
Orphenadrine citrate218
Lansoprazole258
Zonisamide222
Nortriptyline hydrochloride229
Sildenafil citrate224
Levetiracetam287
Tobramycin and dexamethasone214
Mefenamic acid25
Diclofenac epolamine211
Diclofenac212
Lubiprostone220
Minocycline hydrochloride229
Ergocalciferol (vitamin d2)11
Silver sulfadiazine113
Indomethacin136
Aspirin1134
Paroxetine133
Capsaicin 0.025%14
Menthol 5%16
Methyl salicylate124
Cefuroxime axetil117

Dosage forms

Dosage formProductsShare
Tablet17132%
Tablet, film coated9718.2%
Capsule8315.5%
Capsule, delayed release203.7%
Tablet, delayed release183.4%
Kit163%
Tablet, coated142.6%
Capsule, extended release142.6%
Tablet, extended release132.4%
Ointment132.4%
Patch122.2%
Solution101.9%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Gabapentin80425-0595CapsuleGeneric drugs (ANDA)September 11, 2026
Lidocaine80425-0594OintmentGeneric drugs (ANDA)September 10, 2026
Salicor80425-0592PatchOther unapproved drugsAugust 6, 2026
Ramelteon80425-0593TabletGeneric drugs (ANDA)July 27, 2026
Metformin Hydrochloride80425-0591Tablet, film coatedGeneric drugs (ANDA)July 10, 2026
Hydroxyzine hydrochloride80425-0590Tablet, film coatedGeneric drugs (ANDA)July 10, 2026
Famotidine80425-0589Tablet, film coatedGeneric drugs (ANDA)July 10, 2026
Tramadol Hydrochloride80425-0588TabletGeneric drugs (ANDA)June 26, 2026
Ibuprofen and Famotidine80425-0587TabletGeneric drugs (ANDA)June 18, 2026
Meloxicam80425-0586TabletGeneric drugs (ANDA)June 18, 2026
Meloxicam80425-0585TabletGeneric drugs (ANDA)June 18, 2026
Meloxicam80425-0584TabletGeneric drugs (ANDA)June 18, 2026
Propranolol Hydrochloride80425-0583TabletGeneric drugs (ANDA)June 12, 2026
Lidocaine and Menthol80425-0560PatchOver the counter monograph drugsJune 12, 2026
LidoPro80425-0582PatchOver the counter monograph drugsApril 17, 2026
Metaxalone80425-0580TabletGeneric drugs (ANDA)April 17, 2026
Venlafaxine Hydrochloride80425-0581Capsule, extended releaseGeneric drugs (ANDA)April 9, 2026
Methocarbamol80425-0578Tablet, coatedGeneric drugs (ANDA)March 13, 2026
Methocarbamol80425-0577TabletGeneric drugs (ANDA)February 18, 2026
Topiramate80425-0576Tablet, film coatedGeneric drugs (ANDA)February 18, 2026
Naproxen Sodium80425-0574TabletGeneric drugs (ANDA)February 4, 2026
Lidothol ES80425-0561SystemOther unapproved drugsFebruary 2, 2026
Marlido Kit80425-0573KitOther unapproved drugsJanuary 30, 2026
Toronova II SUIK80425-0572Injection, solutionOther unapproved drugsJanuary 23, 2026
Cefuroxime axetil80425-0571Tablet, film coatedGeneric drugs (ANDA)January 16, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.